Gralow, MD, FACP, FASCO, chief medical officer and executive vice president of ASCO, said, People with [IBD], including Crohns disease and ulcerative colitis, are known to have higher risk of developing colorectal cancer
However, our understanding of the function of GLP-1RAs is not complete, and further research, including long-term and large clinical trials are warranted to properly evaluate the causal relationship between GLP-1RAs and the development and progression of various cancers
CBO points out that the studies we have on this topic rely on correlations between [body mass index (BMI)] and health conditions and between health conditions and health care spending, which may or may not be driven by a causal relationship. As CBO notes, there is a correlation between higher BMIs and higher health care spending
The impact of GLP-1 drugs on public health has already been profound